Paul Borm
Founder Shareholder @Nano4Imaging
Signup · Get unlimited contacts
WORK HISTORY
Founder Shareholder @Nano4Imaging
Düsseldorf, DE
Nano4Imaging GmbH produces medical instruments to enable MRI guided interventions. The company holds CE, Health Canada and FDA registration for a MRI compatible guide wire, which is used in congenital heart diseases (CHD) and pulmonary hypertension (PH). Vision is to transfer cathlab procedures to the MRI. Reasons: visibility of target, absence of radiation, superior contrast and hemodynamic parameters (flow) in MRI.
EDUCATION
Radboud University
BSc, Biochemistry, Pharmacology, ananytical chemistry
Utrecht University
Doctor of Philosophy (Ph.D.), Pharmacology and Toxicology
jansenius Hulst
Gymnasium B
University of Düsseldorf
Privat Dozent, Prof., Toxicology
SKILLS
ABOUT PAUL BORM
During his 25 year academic career in ParticleToxicology he conducted research into biomarkers of lung diseases such as in coal miners. He co-founded a high-pact journal (PFT) for particle toxicology and he is the author of more than 250 publications in this field. Since Nanotechnologies feed his activities on regional and global level, and provide inspiration for new developments. In 2011 he founded Nano4Imaging GmbH which focuses on endovascular interventions using interventional MRI. Under his guidance and with EiC support, Nano4Imaging has now developed a special AI supported software TRACKR to guide its devices and markers. In 2025 he joined the Advisory Board of the company, and his activities are on strategic level and concern the classification of so- called PSLT (talc, TiO2, CB) by regulatory bodiesSpecialties: Medical Imaging, Life Sciences, particle toxicology, risk assessment
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.